Edward M. MD Kaye - Aug 5, 2022 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Role
Director
Signature
/s/ John Faurescu, attorney-in-fact for Dr. Kaye
Stock symbol
CYTK
Transactions as of
Aug 5, 2022
Transactions value $
-$471,405
Form type
4
Date filed
8/8/2022, 04:01 PM
Previous filing
Jul 12, 2022
Next filing
Oct 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTK Common Stock Options Exercise $100K +11.4K +90.87% $8.75 24K Aug 5, 2022 Direct F1
transaction CYTK Common Stock Sale -$571K -11.4K -47.61% $50.00 12.6K Aug 5, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTK Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -11.4K -100% $0.00* 0 Aug 5, 2022 Common Stock 11.4K $8.75 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on November 12, 2021.